Neuraxial and Neurolytic Analgesia for Intractable Pain - Full Text View

Neuraxial and Neurolytic Analgesia for Intractable Pain

This study is currently recruiting participants.
Verified by University of Wisconsin, Madison, June 2008

Sponsored by:	University of Wisconsin, Madison
Information provided by:	University of Wisconsin, Madison
ClinicalTrials.gov Identifier:	NCT00167726

Purpose

The purpose of this study is to collect longitudinal data on outcomes of neuraxial or neurolytic procedures in patients with intractable cancer and chronic noncancer pain so that we may contribute to the growing evidence for or against these therapies and to provide data for ongoing quality improvement activities.

Condition

Pain

U.S. FDA Resources

Study Type:	Observational
Study Design:	Case-Only, Prospective

Official Title:	Neuraxial and Neurolytic Analgesia for Intractable Pain

Further study details as provided by University of Wisconsin, Madison:

Estimated Enrollment:	100
Study Start Date:	January 2005
Estimated Study Completion Date:	January 2010

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

This is a prospective case series analysis. Subjects over the age of 18 who are offered neuraxial (epidural or intrathecal) analgesia or neurolytic procedures (e.g. celiac, hypogastric, or sacral nerve plexus block) to treat intractable pain through the UW Interventional Pain Program.

Criteria

Inclusion Criteria:

treated for intractable pain by the UW Interventional Pain Treatment program
inpatient or outpatient

Exclusion Criteria:

less than 18 years of age

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00167726

Contacts


Contact: Andrea Maser	608-265-6544

Locations


United States, Wisconsin
	University of Wisconsin	Recruiting
	Madison, Wisconsin, United States, 53792
	Contact: Andrea Maser 608-265-6544

Sponsors and Collaborators

University of Wisconsin, Madison

Investigators


Principal Investigator:	Nalini Sehgal, MD	University of Wisconsin, Madison

More Information

Responsible Party:	University of Wisconsin School of Medicine and Public Health ( Nalini Sehgal MD )
Study ID Numbers:	2004-0482
First Received:	September 9, 2005
Last Updated:	June 12, 2008
ClinicalTrials.gov Identifier:	NCT00167726
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Pain, Intractable

Signs and Symptoms

Neurologic Manifestations

Pain

Additional relevant MeSH terms:

Nervous System Diseases

ClinicalTrials.gov processed this record on October 07, 2008